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INTRODUCTION  
An emulsion is a system in which one fluid is dispersed in 
another with which it is immiscib le. Separation of the 
phases is prevented by the addition of a suitable surfactant. 
In the vast majority of emulsion research, one of the liquid 
phase is water.  
The term "Nanoemulsion" refers to a thermodynamically  
stable isotropically clear dispersion of two immiscible 
liquids, such as oil and water, stabilized by an interfacial 
film of surfactant molecules. A nanoemulsion is 
considered to be a thermodynamically or kinetically stable 
liquid  dispersion of an oil phase and a water phase, in 
combination with a surfactant. The dispersed phase 
typically comprises small particles or droplets, with a size 
range of 5 nm-200 nm, and has very low oil/water 
interfacial tension. Because the droplet size is less than 
25% of the wavelength of visible light, nanoemulsion are 
transparent. These are formed readily and sometimes 
spontaneously, generally without high-energy input. In 
many cases a co surfactant or co solvent is used in addition 
to the surfactant, the oil phase and the water phase.  
Three types of Nanoemulsion are most likely to be formed  
depending on the composition:  
Oil in water Nanoemulsion wherein o il d roplets are 
dispersed in the continuous aqueous phase  
Water in oil Nanoemulsion wherein water droplets are 
dispersed in the continuous oil phase;  
Bi-continuous Nanoemulsion wherein microdomains of 
oil and water are inter-d ispersed within the system.  
 
Table 1: Differences between emulsion and nanoemulsion 
Emulsion  Nanoemulsion Microemulsion 
Excellent kinetic stability. Kinetically unstable. They posses some kinetic stability 
Thermodynamically  unstable and will 
eventually phase separate. 
Thermodynamically  stable and no phase 
separation occur. 
 Thermodynamically stable 
Emulsions appear cloudy. Nanoemulsions are clear or translucent.  Microemulsion are clear 
Methods involved in preparation of 
emulsion require a large input of energy.  
Methods of preparation do not require 
energy input.  
Methods of preparation do not 
require energy input.  
 
Nanoemulsion is colloidal dispersions composed of an oil 
phase, aqueous phase, surfactant and co surfactant at 
appropriate ratios. Unlike coarse emulsions micronized  
with external energy, nanoemulsion is based on low 
interfacial tension which is achieved by adding a co 
surfactant, which leads to spontaneous formation of a 
thermodynamically stable nanoemulsion. The droplet size 
in the dispersed phase is very small, usually below 140 nm 
in diameter, which makes the nanoemulsion transparent 
liquids.
2
  
In princip le, nanoemulsion can be used to deliver drugs to 
the patients via several routes, but the topical applicat ion 
of nanoemulsion has gained increasing interest. The three 
main factors determining the transdermal permeation of 
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drugs are the mobility of drug in the vehicle, release of 
drug from the vehicle, and permeation of drug into the 
skin. These factors affect either the thermodynamic 
activity that drives the drug into the skin or the 
permeability of drug in the skin, particularly stratum 
corneum. Nanoemulsion improve the transdermal delivery  
of several drugs over the conventional topical preparations 
such as emulsions
3,4 
and gels
5,6
.  
Mobility of drugs in nanoemulsion is more facile
4,6,7
, as 
compared to the  with gel former which will increase its 
viscosity and further decrease the permeation in the skin.
5
 
The superior transdermal flux from nanoemulsion has been 
shown to be mainly due to their high solubilizat ion 
potential for lipophilic and hydrophilic drugs. This 
generates an increased thermodynamic activity towards the 
skin.
4,7,8
 Nanoemulsion may affect the permeability of drug 
in the skin. In this case, the components of nanoemulsion 
serve as permeation enhancers.  
Several compounds used in nanoemulsion have been 
reported to improve the transdermal permeat ion by altering 
the structure of the stratum corneum. For example, short 
chain alkanols are widely used as permeation 
enhancers.
9,10,11
 It is known that oleic acid, a fatty acid  
with one double bond in the chain structure, perturbs the 
lip id barrier in the stratum corneum by forming separate 
domains which interfere with the continuity of the 
multilamellar stratum corneum and may induce highly 
permeable pathways in the stratum corneum.
12,13,14
 
Isopropyl myristate (IPM) is used as a permeat ion 
enhancer in transdermal formulations, but the mechanism 
of its action is poorly understood.
15
 Non-ionic surfactants 
are widely used in topical formulations as solubilising 
agents but some recent results indicate that they may affect 
also the skin barrier function.
16 
It is of interest to explore 
the effects of these components in the organized 
nanoemulsion structures.  
A unique attempt was made
17
 to emulsify coconut oil with 
the help of polyoxyethylene 2-cetyl ether (Brij 52) and 
isopropanol or ethanol, forming stable isotropic dispersion 
thus paving way for use of plant and vegetable oil to be 
used as oil phase in nanoemulsion.  
A combination of surfactants, particularly ionic and non-
ionic, can be very effective at increasing the extent of the 
nanoemulsion region. Examples of non-ionic include 
polyoxyethylene surfactants such as Brij 35 (C12E35) or 
sugar esters such as sorbitan monooleate (Span 80). 
Phospholipids are a notable example of zwitterionic 
surfactants  and exh ibit excellent biocompatib ility. Lecithin  
preparations from a variety of sources including soybean 
and egg are available commercially and contain 
diacylphosphatidylcholine as its major constituent.
18-21
 
Quaternary ammonium alkyl salts form one of the best 
known classes of cationic surfactants, with 
hexadecyltrimethyl ammonium bromide (CTAB) and the 
twin-tailed surfactant didodcecylammonium bromide 
(DDAB) are amongst the most well known (Olla et al., 
1999). The most widely studied anionic surfactant is 
probably sodium bis-2-ethylhexylsulphosuccinate (AOT) 
which is twin-tailed and is a particu larly effective stabiliser 
of w/o microemulsions.
22 
 
 
ADVANTAGES  OF NANOEMULS ION 
 Nanoemulsion is the approach to improve water 
solubility and ultimate bioavailability of lipophilic 
drugs. The nano-sized droplets leading to enormous 
interfacial areas associated with nanoemulsions would 
influence the transport properties of the drug, an 
important factor in sustained and targeted drug 
delivery
38
. 
 Nanoemulsions have been reported to make the 
plasma concentration profiles and bioavailability of 
drugs more reproducible
38-39
. 
 Fine oil droplets empty rapid ly from the stomach and 
promote wide distribution of the drug throughout the 
intestinal tract and thereby min imizing irritation 
frequently encountered with extended contact of the 
drug and gut wall
40
. 
 Higher solubilizat ion capacity than simple micellar 
solutions and their thermodynamic stability offers 
advantages over unstable dispersions such as 
emulsions and suspensions because they can be 
manufactured with little energy input (heat or mixing) 
and have a long shelf life
41
. 
 They also provide ultra low interfacial tension and 
large o/w interfacial areas
41
. 
 They also offer an advantage over existing self 
emulsifying system in terms of rap id onset of action 
(no extra time for dispersion) and reduced intersubject 
variability in terms of GIT fluid volume.  
 They possess high kinetic stability and optical 
transparency resembling to microemulsions
42
. 
 The structures in the nanoemulsions are much smaller 
than the visible wavelength, so most nanoemulsions 
appear optically transparent, even at large loading
42
. 
 They have potential to deliver peptides that are prone 
to enzymat ic hydrolysis in GIT
43
.  
 Nanoemulsions have higher surface area and higher 
free energy than macro emulsions that make them an 
effective transport system.
44
  
 Problems of inherent creaming, flocculation, 
coalescence, and sedimentation are not seen in 
nanoemulsions, which are commonly associated with 
macroemulsions.
45
  
 Nanoemulsions can be formulated in numerous dosage 
foam such as creams, liquids, sprays and foams.
46
  
 It is non-toxic and non-irritant so can be easily applied  
to skin and mucous membranes.  
 Nanoemulsions  is formulated with surfactants, which 
are approved for human consumption (GRAS) so they 
can be taken by enteric route.
47
  
 It is do not damage healthy human and animal cells, 
so nanoemulsions are suitable for human and 
veterinary therapeutic purposes
48
. 
DISADVANTAGES OF NANO EMULS ION 
 The formulat ion of nanoemulsions is an expensive 
process due to size reduction of droplets is very 
difficult as it required a special kind of instruments 
and process methods. For example, homogenizer 
(instrument required for the nanoemulsions 
formulat ion) arrangement is an expensive process. 
More ever microfluid ization and ultrasonication 
(manufacturing process) require large amount of 
financial support.  
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 The stability of nanoemulsions is quite unacceptable 
and produces a big problem during the storage of 
formulat ion for the longer time. Ostwald ripening is 
the main problem associated with unacceptability of 
nanoemulsions formulat ions. Ostwald ripening is due 
to the high rate of curvature of small droplet show 
greater solubility as compared to large drop with a low 
radius of curvature
49-50
. 
PREPARATION OF NANOEMULS ION  
The drug is to be dissolved in the lipophilic part of the 
nanoemulsion i.e. oil and the water phases can be 
combined with surfactant and a cosurfactant is then added 
at slow rate with gradual stirring until the system is 
transparent. The amount of surfactant and cosurfactant to 
be added and the percent of oil phase that can be 
incorporated shall be determined with the help of pseudo-
ternary phase diagram. Ultrasonicator can finally be used 
so to achieve the desired size range for dispersed globules. 
It is then being allowed to equilibrate. Gel may be 
prepared by adding a gelling agent to the above. 
Carbomers (crosslinked polyacrylic acid polymers) are the 
most widely used gelling agent.  
Factors to be considered during preparation of 
nanoemulsion  
Three important conditions:  
 Surfactants must be carefully chosen so that an ultra 
low interfacial tension (< 10-3 mN/m) can be attained 
at the oil / water interface which is a prime requirement 
to produce nanoemulsions.  
 Concentration of surfactant must be high enough to 
provide the number of surfactant molecu les needed to 
stabilize the nano droplets to be produced by an ultra 
low interfacial tension.  
 The interface must be flexib le or fluid enough to 
promote the format ion of nanoemulsions.  
Nanoemulsion, being non-equilibrium systems cannot be 
formed spontaneously. Consequently, energy input 
generally from mechanical devices or from the chemical 
potential of the components is required, Nanoemulsion 
formation by the so called dispersion or high energy 
emulsification method is generally achieved using high 
shear stirring, high pressure homogenizers and ultrasound 
generators.  It has been shown that the apparatus supplying 
the available energy in the shortest time and having the 
most homogeneous flow produces the smaller sizes. High 
pressure homogenizers meet these requirements; therefore, 
they are the most widely used emulsifying machines to 
prepare nanoemulsion.  Generally, the conventional high 
pressure homogenizers work in a range of pressures 
between 50 and 100 Mpa. Pressure as high as 350Mpa 
have been achieved in a recently developed instrument. 
Ultrasonication emulsification is also very efficient in  
reducing droplet size but it is appropriate for s mall 
batches. On the preparation of polymerizable 
nanoemulsion has shown that the efficiency of dispersion 
process is strongly dependent on ultrasonication time at  
different amplitudes and that the more hydrophobic the 
monomer is the longer the sonication time required
39
. 
METHODS OF PREPARATION OF 
NANOEMULS ION  
Phase inversion method  
Fine dispersion is obtained by chemical energy resulting of 
phase transitions occur through emulsification method. 
The adequate phase transitions are produced by changing 
the composition at constant temperature or by changing the 
temperature at constant composition, Phase inversion 
temperature (PIT) method was introduced by Shinoda et al. 
based on principle of the changes of solubility of 
polyoxyethylene- type surfactant with temperature. This 
surfactant becomes lipophilic as increase in temperature 
because of dehydration of polymer chain. At low 
temperature, the surfactant monolayer has a great positive 
spontaneous curvature forming oil swollen micellar 
solution phase
33
.  
 
Table 2: List of oils, surfactants and cosurfactants used for preparation of nanoemulsion 
Oil (Chemical Name) 
 
Surfactant  Cosurfactant  
Captex 355 (Glyceryl 
Tricaory late/Caprate), 
Captex 200 (Propylene 
Dicapry late/Dicaprate Glycol),  
Captex 8000 (Glyceryl Tricaprylate ),  
Witepsol (90:10 % w/w c12 Glyceride tri: 
diesters), 
Myritol 318 (c8/c10 triglycerides), 
1sopropyel myristate (Myristic acid 
isopropyl ester). 
Capryol 90; 
Gelucire 44/14, 50/13;  
Cremophor RH 40;  
Imwitor 191, 308(1), 380, 742, 780 K, 928, 
988;  
Labrafil M 1944 CS, M 2125 CS ;  
Lauroglycol 90;  
PEG MW > 4000;  
Pluro l Oleique CC 497;  
Poloxamer 124 and 188;  
Softigen 701, 767;  
Tagat TO;  
Tween 80.  
TranscutolP;  
Glycerin; Ethylene glycol;   
Propylene glycol;  
Ethanol; 
Propanol.  
 
Sonication method  
Sonication method is best way to prepare nanoemulsions. 
In this method the droplet size of conventional emulsion or 
microemulsions were reduced with the help of sonication 
mechanis m. This method is not applicable for large 
batches, but only small batches of nanoemulsions can be 
prepared by this method
34
. 
Ultrasonic System  
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In ultrasonic emulsification, the energy input is provided 
through so called sonotrodes (sonicator probe) containing 
piezoelectric quartz crystals that can be expand & contract 
in response to alternating electrical voltage. As the tip of 
sonicator probe contacts the liquid, it generates mechanical 
vibration and therefore cavitations occurs, which is the 
main phenomenon responsible for ult rasonically induced 
effects. Cavitation is the format ion and collapse of vapour 
cavities in a flowing liquid.. Such a vapour cavity forms 
when the local pressure is reduced to that of at the 
temperature of the flowing liquid because of local velocity 
changes. The collapse of these cavities causes powerful 
shock waves to radiate throughout the solution in 
proximity to the radiating face of the tip, thereby breaking 
the dispersed droplets. Within the ultrasound range, the 
power availab le varies inversely with the frequency and 
only powerful ultrasound (0-200kHz) is able to produce 
physical and chemical changes such as emulsification.  
Ultrasound can be used directly to produce emulsion, but 
since breaking an interface requires a large amount of 
energy, it is better to prepare coarse emulsion before 
applying acoustic power. Due to small product throughput 
the ultrasound emulsification process main ly applied in  
laboratories where emulsion droplet size as low as 0.2 
micrometer can be obtained
35
.  
Microfluidizer  
It is possible to produce emulsion at much higher pressures 
up to approximately 700 Mpa, in the nozzle of 
microfludizer that is the heart of this device (the 
interaction chamber), two jets of crude emulsion from two 
opposite channels collide with one another. The process 
stream is delivered by a pneumatically powered pump that 
is capable of pressurizing the in-house compressed air 
(150-650 Mpa) up to about 150 Mpa. Forcing the flow 
stream by high pressure through microchannels toward an 
impingement area creates a tremendous shearing action, 
which can provide an exceptionally fine emulsion
36
. 
Jet Disperser  
Forcing the flow stream by high pressure through 
microchannels towards an impregnated area creates a 
tremendous shearing action, which can provide an 
exceptionally fine emulsion. In general, init ial forces in  
turbulent flow along with cavitations are predominantly 
responsible for droplet disruption in microfluidizer. 
Disruption in laminar elongational flow is also possible, 
especially when emulsion has high viscosity.  
In the jet disperser two or more jets of crude emulsion each 
from opposing bores collide with one another but at a 
different design than microfludizer, the diameter of the 
bores injet dispersers are typically 0.3-0.5mm. Finally an 
“orifice plate” is the simplest construction form for a 
homogenizing nozzle. The diameter of orifice bore is of 
same order of magnitude as the jet dispersers and inlet 
head diameter of orifice plate is typically 10-60nm, in jet  
dispersers & orifice plates, droplets are disrupted 
predominantly due to laminar elongational flow ahead of 
the bores. Unlike radial diffusers, the nozzle is  
microflu idizers; jet dispersers and orifice plate contain no 
moving parts, so they can be used at high pressures up to 
300-400 Mpa
37
. 
PHYS ICOCHEMICAL CHARACTERIZATION OF 
NANOEMULS IONS
51-52
 
Particle Size Analysis.  
Rheological Measurements. 
Refractive Index. 
Surface Tension. pH and Osmotic Pressure.  
PATENTS RELATED TO NANOEMULS ION 
Patents are the strongest form of intellectual property 
protection and are essential to the growth of a 
nanotechnology company. Similar to their importance to 
the development of the biotechnology and informational 
technology industries, patents will also play a critical role 
in the success of the global nanotechnology revolution; in 
fact patents are already shaping the nascent and rapidly 
evolving field of nanoscience and small technologies. As 
companies develop the products and processes of 
nantechnology, and begin to seek commercial applications 
for their inventions, securing valid and defensible patent 
protection will be vital to their long term survival.  
Table 3: List of patents related to nanoemulsion 
Patent Application Title  Patent App No. Date  
Topical compositions and methods of detection and treatment 20120039814 2012/02/16 
Cancer vaccine compositions and methods of using the same  20110280911 2011/11/17 
Methods of using nanoemulsion compositions having anti- inflammatory activity  20110200657 2011/08/18 
Stable nanoemulsions for ultrasound-mediated of drug delivery and imaging  20110177005 2011/07/21 
Method for the preparation of nanoparticles from nanoemulsion 20110135734 2011/06/09 
Nanoemulsion formulat ions for direct delivery  20110045050 2011/02/24 
Lyophilized nanoemulsion  20110015266 2011/01/20 
Antimicrobial nanoemulsion compositions and methods 20110070306 2011/03/24 
Nanoemulsion vaccines 20100316673 2010/12/16 
Perfluorocarbon nanoemulsion containing quantum dot nanoparticles and method for 
preparing the same 
20100233094 2010/09/16 
Nanoemulsion of resveratrol-phospholipid complex and method for preparing the 
same and applications thereof 
20100297199 2010/11/25 
Compositions for treatment and prevention of acne, methods for making the 
compositions, and methods of use thereof 
20100226983 2010/09/09 
Stable mixed emulsions 20100069511 2010/03/18 
Oil-in-water nanoemulsion, a cosmetic composition and a cosmetic product 
comprising it, a  process for preparing said nanoemulsion 
20090208541 2009/08/20 
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APPLICATIONS OF NANOEMULS ION  
Nanoemulsions containing pharmaceutically active agents 
can be utilized for the production of pharmaceutical 
preparations, the nanoemulsion being mixed, as the active 
component, with a solid or liquid vehicle suitable for 
therapeutic admin istration. If desired, a special galenic 
form can be imparted to the mixture. The following 
galenic forms of admin istration can be considered, in this 
connection: Ampoules, especially sterile injection and 
infusion solutions; solutions, especially oral liquids, eye 
drops and nose drops which can contain various auxiliary  
substances in addition to the nanoemulsion; aerosols 
without metering feature, and dosing aerosols, which can 
contain propellant gas and stabilizers besides the 
nanoemulsion; hydrophilic and hydrophobic gels and 
ointments containing the nanoemulsion; o/w or w/o creams 
containing the nanoemulsion; lotions and pastes containing 
the nanoemulsion.  
Ocular Delivery 
Oil in water emulsions are being explored for improved 
topical lipophilic drug delivery to the eye. Lipophilic drug 
loaded o/w ocular emulsions provide equivocally a better 
balance between ocular bioavailability improvement and 
patient comfort following topical instillation into the eye 
e.g. Piroxicam, p ilocarpine, indomethacin, cyclosporine 
A
56
. 
Percutaneous Route  
Many drugs exh ibit low skin penetration, which results in 
poor efficacy. As opposed to common chemical skin  
penetration enhancers, organic solvents, which are 
generally associated to some degree with skin irritation, 
toxicity and sensitizat ion, a solvent free topical vehicle 
based on drug entrapment in the o/w emulsion droplets of 
submicron size is more efficacious in terms of 
percutaneous absorption with possibly devoid of adverse 
effects. In addition, the uniqueness of the large internal 
hydrophobic core of o/w submicronized emulsion droplets 
allows high solubilizat ion capacity for water insoluble 
topically active medicaments and also aids in carrying 
water, an excellent softener, to the skin e.g. NSAIDs, 
diazepam, α-tocopherol, antifungal drugs (econazole or 
miconazo le nitrate), EMLA (Eutectic mixtures of local 
anaesthetic) has proven to be a useful medication for 
children. It is an emulsion containing a mixture of 
lidocaine and prilocaine. This cream gives an effective 
deep sedation
56
. 
Nasal Route  
The nasal route has received great attention due to number 
of advantages over parenteral and oral administration 
especially by-passing the liver. Nanoemulsions increase 
absorption by solubilizing the drug in the inner phase of an 
emulsion and prolonging contact time between emulsion 
droplets and nasal mucosa e.g. a lipid soluble rennin-
inhibitor was incorporated into an o/w emulsion. Enhanced 
and prolonged in vivo nasal absorption was observed in 
emulsion compared to aqueous suspension. Other drugs 
which have been formulated for nasal delivery are insulin 
and testosterone
56,57
. 
Use of Nanoemulsion in Cosmetics  
Nanoemulsions have recently become increasingly 
important as potential vehicles for the controlled delivery  
of cosmetics and for the optimized d ispersion of active 
ingredients in particular skin layers.  
Due to their lipohilic interior, nanoemulsions are more 
suitable for the transport of lipophilic compounds than 
liposomes. Similar to liposomes, they support the skin 
penetration of active ingredients and thus increase their 
concentration in the skin. Another advantage is the small-
sized droplet with its high surface area allowing effective 
transport of the active to the skin. Furthermore, 
nanoemulsions gain increasing interest due to their own 
bioactive effects. This may reduce the trans -epidermal 
water loss (TEWL), indicating that the barrier function of 
the skin is strengthened. Nanoemulsions are acceptable in 
cosmetics because there is no inherent creaming, 
sedimentation, flocculation or coalescence observed within 
macroemulsions. The incorporation of potentially irritating 
surfactants can often be avoided by using high-energy 
equipment during manufacturing
58
.  
Antimicrobial Nanoemulsions  
Antimicrobial nanoemulsions are oil-in-water droplets that 
range from 200-600 nm. They are composed of oil and 
water and are stabilized by surfactants and alcohol. The 
nanoemulsion has a broad spectrum activ ity against 
bacteria (e.g., E. coli, Salmonella, S. aureus), enveloped 
viruses (e.g., HIV, Herpes simplex), fungi (e.g., Candida, 
Dermatophytes), and spores (e.g., anthrax). The 
nanoemulsion particles are thermodynamically driven to 
fuse with lipid-containing organis ms. This fusion is 
enhanced by the electrostatic attraction between the 
cationic charge of the emulsion and the anionic charge on 
the pathogen. When enough nanoparticles fuse with the 
pathogens, they release part of the energy trapped within 
the emulsion. Both the active ingredient and the energy 
released destabilize the pathogen lipid membrane, resulting 
in cell lysis and death
59
. 
CONCLUS ION 
Although high energy emulsification method is 
traditionally used for the preparation of nanoemulsion 
formulat ion but low emulsion emulsification method now 
create an attraction due to their wide application and 
advantages as a formulat ion and stability aspects. The 
applications of nanoemulsion are limited by the instability. 
Stability of formulation may be enhanced by controlling 
various factors such as type and concentration of surfactant 
and co surfactant, type of oil phase, methods used, process 
variables and addition of additives used over the inter 
phases of nanoemulsion formulation. Overall 
nanoemulsion formulat ion may be considered as effective, 
safe and patient compliance formulat ion for the delivery of 
pharmaceuticals and in cosmetic science after controlling 
the instability factors.  
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